Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001839882-24-038905
Filing Date
2024-11-13
Accepted
2024-11-13 16:06:36
Documents
1
Group Members
AFFINITY HEALTHCARE FUND, LP

Document Format Files

Seq Description Document Type Size
1 AMENDMENT TO SCHEDULE 13G nextcure-sc13ga_093024.htm SC 13G/A 40692
  Complete submission text file 0001839882-24-038905.txt   42272
Mailing Address 9000 VIRGINIA MANOR ROAD, SUITE 200 BELTSVILLE MD 20705
Business Address 9000 VIRGINIA MANOR ROAD, SUITE 200 BELTSVILLE MD 20705 240-399-4900
NextCure, Inc. (Subject) CIK: 0001661059 (see all company filings)

EIN.: 475231247 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91004 | Film No.: 241454120
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 767 THIRD AVENUE NEW YORK NY 10017
Business Address 767 THIRD AVENUE NEW YORK NY 10017 917-826-4533
Affinity Asset Advisors, LLC (Filed by) CIK: 0001773195 (see all company filings)

EIN.: 821567490 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A